Has Becton Dickinson & Company had other FDA enforcement actions?

Yes. Argus HQ has recorded 14 total FDA actions tied to Becton Dickinson & Company: 0 warning letters, 14 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2023-03-22; Argus observed and indexed it on 2026-07-16.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · device_recall · high

Becton Dickinson & Company — Class II recall: BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed f…

Name: FDA Recall Record — Becton Dickinson & Company
Creator: Argus HQ
Published: 2023-03-22
License: https://argushq.ai/methodology

Event date: 2023-03-22 00:00:00Z
Observed: 2026-07-16 23:20:09Z
Source ID: Z-1244-2023
Payload hash: ece81da1e97d54895ac6ec39…

Summary

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection. Status: Ongoing.

Entities

Becton Dickinson & Company

View source record ↗

Frequently asked questions

Has Becton Dickinson & Company had other FDA enforcement actions?: Yes. Argus HQ has recorded 14 total FDA actions tied to Becton Dickinson & Company: 0 warning letters, 14 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2023-03-22; Argus observed and indexed it on 2026-07-16.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2023). Becton Dickinson & Company — Class II recall: BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed f…. Digital Empire LLC. Retrieved from https://argushq.ai/events/fda-recall-becton-dickinson-and-company-z-1244-2023

MLA

"Becton Dickinson & Company — Class II recall: BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed f…." Argus HQ Research, Digital Empire LLC, 2023, argushq.ai/events/fda-recall-becton-dickinson-and-company-z-1244-2023.

Chicago

Argus HQ Research. "Becton Dickinson & Company — Class II recall: BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed f…." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/events/fda-recall-becton-dickinson-and-company-z-1244-2023.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_becton_dickinson_and_company_z_1244_2023_2023,
  title = {Becton Dickinson & Company — Class II recall: BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed f…},
  author = {{Argus HQ Research}},
  year = {2023},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/events/fda-recall-becton-dickinson-and-company-z-1244-2023},
  note = {Accessed: July 17, 2026}
}

Informational only. Not legal, financial, or medical advice.